The Australian Bronchiectasis Registry (ABR), established in 2015, aims to evaluate clinical phenotypes of Australians with bronchiectasis.
Their first report, published in Respiratory Medicine (Australian adults with bronchiectasis. The first report from the Australian Bronchiectasis Registry) provides information on the baseline characteristics of the ABR adult cohort and assesses the influence of disease severity and exacerbation phenotype on patient quality of life and health care utilisation.
The data reveals that many patients with bronchiectasis have normal spirometry. It also demonstrates the negative influence of frequent exacerbations on quality of life and health care utilisation and highlights a clinical phenotype that could be targeted in a treatable traits approach to bronchiectasis managment.